|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eli Lilly’s obesity pill Foundayo continues to trail Novo Nordisk’s rival Wegovy pill in terms of early demand. Leerink analysts said Foundayo was prescribed about 7,300 times in its fourth week on the market — roughly a quarter of the prescriptions written for oral Wegovy in its fourth week post-launch. But the analysts noted that Foundayo’s stats are "significantly understated." Meanwhile, Lilly is ramping up its efforts to build brand familiarity, with executives recently touting a "full scale" direct-to-consumer and TV launch coming in the third quarter. |
|
|
|
Nicole DeFeudis |
Editor, Endpoints News
@Nicole_DeFeudis
|
|
|
|
 |
|
FDA Commissioner Marty Makary with President Donald Trump in the Oval Office (Francis Chung/Politico via AP Images) |
|
|
|
by Drew Armstrong
|
President Donald Trump is planning to fire FDA Commissioner Marty Makary, the Wall Street Journal reported on Friday. The plans haven't been finalized and could... | |
|
|
|
|
|
|
by Kyle LaHucik
|
Odyssey Therapeutics pulled together $279 million from its initial public offering, the autoimmune disease drug developer said Thursday night. Odyssey began trading on the Nasdaq... | |
|
|
|
|
|
|
by Anna Brown
|
Daiichi Sankyo is scrapping plans to build antibody-drug conjugate manufacturing capacity and recorded an "extraordinary loss" of 149.4 billion Japanese yen ($950 million) after overpromising... | |
|
|
|
|
|
|
by Andrew Dunn
|
RIO DE JANEIRO — Mazdak Abulnaga should be the poster child for the type of employee pharma companies want to hire this year. Abulnaga, a... | |
|
|
|
|
|
|
by Ayisha Sharma
|
Capricor Therapeutics said Thursday it has filed a lawsuit against Nippon Shinyaku over a distribution and commercialization agreement for deramiocel, a cell therapy candidate for... | |
|
|
|
 |
|
|
|
by Alex Hoffman, Kyle LaHucik
|
→ It didn’t take long for Natalie Holles to rebound after the decision to wind down operations at her previous company. She |
|
|
